<div id="readability-page-1"><p>Geneva Capital Management LLC grew its position in shares of  Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 11.2% during the third quarter, according to its most recent filing with the SEC. The firm owned 535,742 shares of the company's stock after acquiring an additional 53,810 shares during the period. Geneva Capital Management LLC owned about 0.20% of Ryan Specialty worth $30,194,000 at the end of the most recent quarter.</p><div><p><span></span><span>Get <strong>Ryan Specialty</strong> alerts:</span></p></div><ul><li>3 2021 IPOs Likely To Notch Further Big Price Gains </li></ul><p>Other institutional investors and hedge funds also recently made changes to their positions in the company. Royal Bank of Canada boosted its position in shares of  Ryan Specialty by 10.6% during the first quarter. Royal Bank of Canada now owns 59,639 shares of the company's stock valued at $4,406,000 after purchasing an additional 5,739 shares in the last quarter.  AQR Capital Management LLC raised its holdings in  Ryan Specialty by 25.1% in the first quarter. AQR Capital Management LLC now owns 4,972 shares of the company's stock worth $367,000 after purchasing an additional 998 shares in the last quarter.  Goldman Sachs Group Inc. lifted its position in  Ryan Specialty by 46.3% during the first quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company's stock valued at $27,787,000 after buying an additional 119,055 shares during the period.  UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in  Ryan Specialty by 11.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company's stock valued at $24,586,000 after buying an additional 33,667 shares during the period.  Finally, AGF Management Ltd. boosted its holdings in shares of  Ryan Specialty by 11.1% during the 2nd quarter. AGF Management Ltd. now owns 43,276 shares of the company's stock valued at $2,942,000 after buying an additional 4,312 shares in the last quarter. Hedge funds and other institutional investors own  84.82% of the company's stock. </p><h2>Ryan Specialty Stock Performance</h2><p>Shares of RYAN stock opened at $36.40 on Wednesday. The company has a market capitalization of $9.62 billion, a price-to-earnings ratio of 86.66, a price-to-earnings-growth ratio of 0.99 and a beta of 0.65. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. Ryan Specialty Holdings Inc. has a one year low of $36.38 and a one year high of $77.16. The company's 50-day moving average is $45.57 and its 200 day moving average is $51.56. </p><p>Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.05). Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The firm had revenue of $751.21 million during the quarter, compared to analysts' expectations of $777.43 million. During the same period last year, the firm posted $0.45 earnings per share. The firm's quarterly revenue was up 13.2% on a year-over-year basis.  Sell-side analysts expect that  Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year. </p><h2>Ryan Specialty Increases Dividend</h2><p>The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 24th were paid a dividend of $0.13 per share. The ex-dividend date was Tuesday, February 24th. This represents a $0.52 annualized dividend and a yield of 1.4%. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.12. Ryan Specialty's dividend payout ratio (DPR) is 123.81%. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of analysts have recently weighed in on RYAN shares. TD Cowen  reaffirmed a &#34;buy&#34; rating on shares of Ryan Specialty in a research report on Wednesday, November 26th. Barclays dropped their price objective on shares of Ryan Specialty from $58.00 to $52.00 and set an &#34;overweight&#34; rating on the stock in a research note on Friday, February 13th. Cantor Fitzgerald decreased their target price on shares of Ryan Specialty from $52.00 to $45.00 and set a &#34;neutral&#34; rating for the company in a research note on Tuesday, February 17th. Keefe, Bruyette &amp; Woods lowered their target price on shares of Ryan Specialty from $65.00 to $55.00 and set an &#34;outperform&#34; rating for the company in a report on Friday, February 13th. Finally, Jefferies Financial Group initiated coverage on Ryan Specialty in a research report on Monday, December 1st. They issued a &#34;hold&#34; rating and a $64.00 price target on the stock. One investment analyst  has rated the stock with a Strong Buy rating, eight have issued  a Buy rating, five have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of &#34;Hold&#34; and an average target price of $56.87.</p><p><b>Read Our Latest Stock Report on Ryan Specialty</b></p><h2>Insiders Place Their Bets</h2><p>In related news, CEO Timothy William Turner sold 129,570 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the sale, the chief executive officer directly owned 12,553 shares of the company's stock, valued at $672,966.33. This trade represents a 91.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Patrick G. Ryan, Jr. acquired 25,500 shares of Ryan Specialty stock in a transaction that occurred on Monday, February 23rd. The stock was acquired at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. This represents a 6.33% increase in their position. The disclosure for this purchase is available in the SEC filing. 52.21% of the stock is currently owned by company insiders. </p><h2>Ryan Specialty Profile</h2> (Free Report)<p>Ryan Specialty Group, Inc <span>NYSE: RYAN<span></span></span> is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.  </p><p>Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.</p><h2>Read More</h2><ul><li>Five stocks we like better than Ryan Specialty</li><li>The gold chart Wall Street is terrified of…</li><li>What a Former CIA Agent Knows About the Coming Collapse</li><li>Elon Musk already made me a “wealthy man”</li><li>Unlocked: Elon Musk’s Next Big IPO</li><li>1,500 Banks Just Handed the Fed Your Bank Account</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJZQU4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJZQU4"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Ryan Specialty Right Now?</h2><p>Before you consider Ryan Specialty, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.</p><p>While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

RYAN

<p>Geneva Capital Management LLC increased its stake in Ryan Specialty Holdings Inc. by 11.2% in Q3, acquiring 53,810 shares, bringing its total to 535,742 shares valued at $30.19 million. Other institutional investors also raised their positions. Ryan Specialty's stock opened at $36.40, with a market cap of $9.62 billion. The company reported Q4 earnings of $0.45 per share, missing estimates, and announced a quarterly dividend of $0.13 per share, up from $0.12. Analysts have mixed ratings on the stock, with target prices ranging from $45 to $58.</p>

Geneva Capital Management LLC Purchases 53,810 Shares of Ryan Specialty Holdings Inc. $RYAN